Surgical perspective on invasive Candida infections

Area of Science:

• Infectious Diseases
• Critical Care Medicine
• Surgical Infections

Background:

• Invasive and disseminated Candida infections are a major cause of morbidity and mortality in surgical intensive care units (ICUs).
• Risk factors include antibiotic use, central venous catheters, total parenteral nutrition, burns, immunosuppression, and markers of illness severity (e.g., APACHE score > 10, prolonged ventilation).

Purpose of the Study:

• To highlight the significance of Candida colonization as a predictor of invasive disease in critically ill surgical patients.
• To emphasize the need for prophylaxis or early treatment in high-risk individuals to prevent life-threatening invasive/disseminated infections.
• To discuss diagnostic and therapeutic strategies for invasive Candida infections in surgical ICU settings.

Main Methods:

• Review of clinical data and existing literature on invasive and disseminated Candida infections in surgical ICUs.
• Analysis of diagnostic challenges, noting the limitations of laboratory tests for early detection.
• Evaluation of treatment options, including fluconazole and amphotericin B, based on patient severity and infection stage.

Main Results:

• Candida colonization can predict invasive disease in critically ill surgical patients.
• Diagnosis often relies on clinical suspicion due to insufficient sensitivity and specificity of laboratory tests.
• Fluconazole is effective for most invasive/disseminated Candida infections, while amphotericin B is preferred for the most critically ill.

Conclusions:

• Early diagnosis and prompt systemic treatment are essential for managing invasive/disseminated Candida infections.
• Prophylaxis and early treatment with less toxic agents may reduce the need for more aggressive therapies in severely ill patients.
• A proactive approach to managing Candida infections in high-risk surgical ICU patients is warranted.